Hydrops fetalis
Immune hydrops fetalis is caused by red blood cell alloimmunisation haemolytic disease. All other causes are described as non-immune hydrops fetalis (NIHF)
Overview
Immune hydrops fetalis is caused by red blood cell alloimmunisation haemolytic disease. All other causes are described as non-immune hydrops fetalis (NIHF). Hydrops is a symptom of a wide range of conditions which have resulted in an imbalance in fetal fluid between the vascular and interstitial space.¹
Diagnostic criteria are fluid in at least two body cavities (pleural space, pericardial space, peritoneal space, skin or placental enlargement). The prognosis depends on associated prematurity, the underlying cause, the severity of any associated pulmonary hypoplasia and the severity of the ongoing post-natal fluid accumulation (with problems of infection and malnutrition).²
Studies have found a perinatal mortality rate of up to 57%.³,⁴,⁵Mortality and morbidity appears dependent on cause and gestational age at diagnosis. There is high risk for premature delivery. Neonatal mortality remains high at 35% with an overall mortality of 43% at one year. There is one retrospective review reporting normal developmental outcome in half of 56 cases followed-up at one year and is more likely when NIHF is associated with tachyarrhythmia, congenital chylothorax, meconium peritonitis and parvovirus.⁴
Resuscitation
Any baby known to have NIHF should be delivered at a tertiary centre. Find out about the size of pleural effusions and severity of the hydrops from obstetric staff before delivery. It is important to prepare equipment before delivery. Resuscitation and stabilisation is often difficult. The level III specialist should be informed and may well need to attend the delivery. A senior neonatal nurse should also attend. It may be necessary to drain pleural effusions or ascites in the delivery room, at the same time as resuscitating the baby.
Associations with Non-Immune Hydrops
There is a long list of possible causes of NIHF - see table below.
Half of the reported causes of NIHF comprise of cardiovascular anomalies/arrhythmias (21.4%), chromosomal abnormalities (12.5%) or are idiopathic - unexplained (18.2%).⁶
The images to the right demonstrate an infant with hydrops - in this case bilateral pleural effusions, ascites and oedema. The cause of this baby's hydrops was thought to be a congenital chylothorax. Baby was managed with dietary maniuplation using Monogen, without re-accumulation of pleural effusions. Baby was changed to breast feeding uneventfully at three weeks of age.
Congenital Chylothorax
Lymphatic dysplasia, predominantly seen as chylothorax, contributes up to 15% of NIHF cases.⁶,⁷ The pleural fluid is serous until milk feeding begins and it turns chylous. Diagnosis is based on a high lymphocyte presence and protein concentration in the pleural fluid, in addition triglyceride and lipoproteins are present with feeding.
There is a risk of loss of anticoagulant factors and immunoglobulins along with malnutrition. Medium chain triglycerides are absorbed directly into the portal vein, bypassing lymphatic drainage. Enteral feeds are usually started with an MCT based formula while waiting for the chylous leakage to improve. The usual clinical course may take longer than 4 weeks to resolve. Note - MCT formulas do not contain essential fatty acids and may need supplementing if used for an extended period.
Evidence for the use of octreotide is based on collective case reports with a range of success.⁸There is no standard treatment recommendation for the use of octreotide although it appears to be safe in neonates.⁹⁻¹²
Pathophysiological mechanism of NIHF
(Adapted from reference Bellini 2012)
Investigations
Many of these may have been done antenatally. Particular clinical findings may indicate other investigations for aetiology. Target investigations at clinical features. Collect cord blood EDTA and clotted samples.
Anaemia | Evidence of fetal anaemia. Maternal blood group and antibodies. Baby blood group and Coombs. Early haemoglobin/PCV. Maternal Kleihauer |
Biochemistry | Liver function including albumin/protein Renal function |
Cardiac rhythm in utero | Evidence from ultrasound scans and CTGs. Post-natal ECG + monitoring |
Fluid examination | Protein and albumin Cell cytology (commonly finding marked lymphocytosis). Triglyceride levels after feeding started |
Placenta | Macroscopic examination, histology and Toxoplasma PCR |
Ultrasound | Head, heart, chest, abdomen |
X-rays | Chest, abdomen and long bones (skeletal abnormalities and congenital infection). Further CT/MRI as indicated by clinical course and other results. |
Genetics | SNP-Array if not performed antenatally +/- targeted gene testing (Discuss with Genetic services). DNA sample sent for storage Consider a skeletal survey |
Hb electrophoresis | |
Metabolic testing | If no other cause is found discuss with metabolic services regarding appropriate testing, for example consider lysosomal disorders. |
Infective causes
Parvovirus | Fetal anaemia that may have recovered PCR, IgG and IgM titres Send baby/cord serum. |
CMV | Urine culture/PCR. Serum for CMV PCR. |
Toxoplasma | Maternal and baby blood, placenta and amniotic fluid PCR Baby/cord IgM. |
Syphilis | Maternal serology (VDRL) Baby/cord serology. |
Congenital hepatitis | Maternal hepatitis B serology Baby LFTs and liver US. |
Rubella | Maternal serology before pregnancy Urine ± CSF PCR. WBC for rubella PCR Serum IgM. |
Herpes-Simplex | WBC PCR. |
Varicella | Other features of congenital varicella. |
Look for supportive evidence with long bone X-rays, cerebral US/CT and ophthalmic exam.
Cardiovascular | |||
SVT Heart block Truncus arteriosus Coxsackie myocarditis |
Hypoplastic Left Heart Syndrome Endocardial fibroelastosis VSD/AV canal Premature closure of foramen ovale |
Premature closure of PDA Tumours (rhabdomyomas) Arterial calcification Cardiomyopathy (e.g. carnitine deficiency) |
AV malformations Any cause of heart failure |
Chromosomal | |||
Trisomy 21 | Triploidy | 45XO (Turner's) | Many others reported |
Dysmorphic Syndromes | |||
Neurological | |||
Encephalocoele Agenesis of the corpus callosum |
Tuberous sclerosis | Vein of Galen aneurysm | Arthrogryposis |
Gastrointestinal | |||
Jejunal atresia Midgut volvolus |
Meconium peritonitis Hepatitic fibrosis |
Hepatic vascular malformations | Familial cirrhosis and portal hypertension |
Genitourinary | |||
Congenital nephrotic syndrome Urethral obstruction and renal dysplasia |
Polycystic kidneys | Renal vein obstruction | Vaginal and uterine abnormalities |
Haematological | |||
Twin-twin transfusion Rhesus isoimmunisation |
Feto-maternal haemorrhage α-thalassaemia (homozygous) |
Fetal anaemia or blood loss G6PD deficiency |
Pyruvate kinase deficiency |
Lymphatic | |||
Chylothorax | Congenital lymphangectasia | Cystic hygroma of neck | Noonan's Syndrome |
Infective | |||
Parvovirus CMV Toxoplasma |
Syphilis Leptospirosis Chagas Disease |
Congenital hepatitis Rubella Herpes simplex |
Varicella |
Respiratory | |||
Diaphragmatic hernia Cystic adenomatoid malformation |
Hamartoma Tracheo-oesophageal fistula |
Atresia of right main bronchus Sequestration |
Pulmonary lymphangiectasia Mediastinal teratoma |
Other | |||
Retroperitoneal fibrosis | |||
Skeletal | |||
Osteogenesis imperfecta Asphyxiating thoracic dystrophy |
Thanatophoric dwarfism Achondrogenesis |
Hyperphosphatasia | Saldino-Noonan dwarfism |
Tumours | |||
Teratoma | Neuroblastoma | Haemangioma | |
Placental/Umbilical | |||
True knot | UV thrombosis | Placental chorioangioma | UA aneurysm |
Maternal | |||
Diabetes | Preeclampsia | Drugs (i.e. indomethacin) | |
Metabolic | |||
Gaucher's Disease GM1 gangliosidosis |
Hurler's Syndrome (MP 1H) Morquio (MP IVb) |
MP type VII Mucolipidosis type I and II |
Sialic acid storage disease Galactosialidosis |
This list is not comprehensive! Also it does not give an idea of how common conditions may be.